Cresco Labs (CRLBF) Net Income towards Common Stockholders (2020 - 2026)

Cresco Labs' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.3 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 8.04% year-over-year to -$13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 79.26% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
• Net Income towards Common Stockholders was -$13.3 million for Q1 2026 at Cresco Labs, up from -$85.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.7 million in Q4 2024 and bottomed at -$161.3 million in Q4 2022.
• A 5-year average of -$35.2 million and a median of -$16.3 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 115.22% — and 2025, when it sank 1604.87%.
• Cresco Labs' Net Income towards Common Stockholders stood at -$161.3 million in 2022, then surged by 101.63% to $2.6 million in 2023, then surged by 115.22% to $5.7 million in 2024, then sank by 1604.87% to -$85.3 million in 2025, then soared by 84.45% to -$13.3 million in 2026.
• Business Quant data shows CRLBF's Net Income towards Common Stockholders at -$13.3 million in Q1 2026, -$85.3 million in Q4 2025, and -$17.3 million in Q3 2025.